Clinical Trial Update: Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and efficacy of high-dose melphalan hydrochloride for injection in multiple myeloma patients undergoing autologous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan hydrochloride for injection (melphalan hydrochloride)

Snippet

Sponsor: CASI Pharmaceuticals (China) Co., Ltd. | Conditions: Multiple Myeloma | Phase 4 | Status: COMPLETED